Reference no: EM13688096

Elizabeth Pharmaceutical produces several medicines. Each compound can be sold at the split-off point or processed further. The following results apply to March:

Medicines Sales Value at Split-off Point Costs of Additional Processing Sales Value After Additional Processing
Savior I $19,000 $5,300 $26,000
Savior II 23,500 10,500 33,000
Savior III 16,000 9,500 25,000

After determining which products should be sold at the split-off point and which should be processed further, the total revenue provided by these three products would be

$84,000.

$58,500.

$77,000.

$65,500.